Information for medical professionals
Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine
ISTH Statement on COVID-19 and Venous Thromboembolism (VTE)
A Systematic Approach for Managing Venous Thromboembolism in Patients with COVID-19: A Multinational Consensus Statement from the International Society on Thrombosis and Haemostasis (ISTH) on Behalf of the International Thrombosis Community
Our Society contributed to this statement together with 70 other organizations around the world
This information can also be found on the ISTH Website: https://www.isth.org/news/517212
AHA/ISTH SCIENTIFIC STATEMENT
Venous Thromboembolism Research Priorities
Venous thromboembolism is a major cause of morbidity and mortality. The impact of the US Surgeon General’s The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism in 2008 has been lower than expected given the public health impact of this disease. This scientific statement highlights future research priorities in venous thromboembolism, developed by experts and a crowdsourcing survey across 16 scientific organizations.
Recommendations for the management of coagulopathies associated with COVID-19
AVAILABLE NOW: documents on anticoagulation in COVID-19 prepared by a group of national experts
- BSTH Anticoagulation Management in COVID19 patients
- Anticoagulation algorithm 1- Hospitalized-at discharge
- Anticoagulation algorithm 2- Non-hospitalized
- Executive board members BSTH: Prof Cécile Oury (ULiège, President), Dr Thomas Vanassche (UZ Leuven, Vice-President), Dr Kristel Vandenbosch (CHU Liège, Treasurer), Christelle Orlando (UZ Brussel, Secretary)
- UAntwerpen: Prof Alain Gadisseur (UZ Antwerepen) (BSTH member, former President)
- VUB: Prof Kristin Jochmans (UZ Brussel) (BSTH member, former President)
- UCL: Prof Cedric Hermans (Woluwe Clinique St Luc) (BSTH members)
- ULB: Prof Serge Motte (Hôpital Erasme) (BSTH member, former President)
- ULiège: Dr Muriel Sprynger (CHU Liège), President of the Belgian Working Group of Angiology (BSTH member); Dr Pierre Péters (CHU Liège) (BSTH member)
- KULeuven: Prof Peter Verhamme (UZ Leuven) (BSTH member); Prof Christophe Vandenbriele (UZ Leuven) (BSTH member)
- UGent: Prof Harlinde Peperstraete (UZ Gent) (BSTH member)
- Dr Jean-Marc Minon (CHR Citadelle – Hôpital public de Liège) (BSTH member)
- Dr Roel Van Giels (Domus Medica)
- Dr Patrick Emonts (Groupement des gynécologues obstétriciens de langue française de Belgique, GGOLFB, CHU Liège)
- Dr Isabelle Dehaene (Vlaamse Vereniging voor Obstetrie en Gynaecologie, VVOG, UZ Gent)
ISTH recommandations and practical guidance
ISTH recommendations and practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19
BSTH database of special haemostasis assays
Links to: BSTH database of special haemostasis assays in Belgium
BSTH working groups
- Thrombosis Guidelines Group (TGG)
- Bleeding Disorders Group (BDG)
- BSTH working group on fibrinogen
Interested collaborators are continuously looked for.
Please contact prof. Peter Verhamme (TGG) or prof. Alain Gadisseur (BDG)
Brochures & booklets
Anticoagulation booklets
Order booklets
"New oral anticoagulants (NOACs)" brochures
Order brochure
Hemophilia brochures
Order brochure